We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development
News

CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development

CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development
News

CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development

Stem cell-derived pancreatic beta cells transplanted in mice. In the left the cells carrying insulin mutations are shown in green due to the cellular stress reaction. In the right the mutation-corrected healthy beta cells are red. Image credit: Otonkoski Lab
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers at the University of Helsinki, Finland, have described mechanisms linking chronic cellular stress to the poor development of the insulin-producing cells.

Insulin is secreted from the beta cells which are located in the pancreas, and it is crucial for the maintenance of normal blood sugar levels. Deficiency of insulin leads to diabetes, characterized by elevated blood sugar. Diabetes most commonly presents in childhood as Type 1 diabetes and in adults as Type 2 diabetes.

Sometimes diabetes is diagnosed already in very small babies, during the first six months of life. In these cases, mutations in the gene encoding insulin are often found. 

These mutations are only found in one copy of the gene; that means that half of the produced insulin is normal, which should be enough to secure normal blood sugar. However, this is not the case: insulin secretion stops totally after a few months. It is believed that this is caused by a toxic effect of the mutant insulin inside the cell, but the exact mechanisms are poorly understood.

Mutant insulin is known to cause a chronic stress reaction in the beta cell, and it has been thought that this leads to the death of the cell. It is important to understand the detailed consequences of beta-cell stress, because this may help to develop drugs for the prevention of both rare and common forms of diabetes.

“We now had the chance to test this with real patient-derived cells”, tells Professor Timo Otonkoski from the University of Helsinki.

Researchers created a human disease model using stem cells from people carrying insulin gene mutations; then they corrected cells using a gene editing technique called CRISPR. The mutant and corrected stem cells were then induced to turn into insulin-secreting beta cells and the researchers followed the function of the cells after transplanting them in mice.

“The main finding of the study was that these cells do not die from the chronic stress, but their growth and development is disturbed. These effects are mediated through processes that could potentially be targeted by drugs”, Dr. Diego Balboa says.

“In this study, we describe mechanisms linking chronic cellular stress to the poor development of the insulin-producing cells. A strongly reduced number of beta-cells will cause diabetes immediately, but even a milder defect will increase the risk of diabetes later in life. Understanding the molecular mechanisms of these processes may help in devising ways to preserve the mass and function of beta cells”, Otonkoski states.

This article has been republished from materials provided by the University of Helsinki. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference:

Balboa, D., Saarimäki-Vire, J., Borshagovski, D., Survila, M., Lindholm, P., Galli, E., . . . Otonkoski, T. (2018). Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. ELife, 7. doi:10.7554/elife.38519

Advertisement